4//SEC Filing
Robbins Andrew R 4
Accession 0000899243-20-033232
CIK 0001622229other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 9:09 PM ET
Size
9.8 KB
Accession
0000899243-20-033232
Insider Transaction Report
Form 4
Robbins Andrews R
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-12-07+456,693→ 456,693 totalExercise: $12.76Exp: 2030-12-07→ Common Stock (456,693 underlying)
Footnotes (1)
- [F1]This stock option shall vest over a four year period as follows: 1/4th of the option shall vest one year after the vesting start date; then 1/48th of the option shall vest monthly over the remaining three year period.
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001590157
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 9:09 PM ET
- Size
- 9.8 KB